$50 for your first 3 months Get the print edition and steer from crisis to recovery
Add this topic to your myFT Digest for news straight to your inbox
Pharmaceutical company formerly known as Valeant keeps shedding assets from past deal spree
Drugmaker’s shares climb 12% in early trading after earnings beat estimates
Drugmaker reaffirms full-year profit target as third-quarter beats expectations
Pershing Square founder has lost his groove
Drugmaker gives up unit for nothing up front less than three years after paying $1bn
Pharma business models have been disrupted in two short years
Drugmaker exceeds results expectations after accounting scandal
Shares climb in struggling US drugmaker after appointment
Tax gain helps Canadian drugmaker post first-quarter profit despite sliding sales
China plans to introduce a bond trading link between Hong Kong and the mainland
Ill-fated pharma bets and turmoil at AIG put pressure on hedge fund star
The hedge fund is right to cut its losses but the reputational damage is severe
Pershing Square hedge fund lost more than 90% on investment of more than $3.2bn
International Edition
